Ra Pharmaceuticals Inc
(RARX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 0 | 0 | 0 | 0 | 3,044 |
| Gross Profit | N/A | N/A | 0 | N/A | 3,044 |
| Operating Expenses | 12,812 | 11,481 | 10,993 | 8,121 | 7,590 |
| Operating Income | -12,812 | -11,481 | -10,993 | -8,121 | -4,546 |
| Other Income | 149 | 121 | 87 | 7 | -260 |
| Pre-tax Income | -12,663 | -11,360 | -10,906 | -8,114 | -4,806 |
| Net Income Continuous | -12,663 | -11,360 | -10,888 | -8,114 | -4,806 |
| Net Income | $-12,663 | $-11,360 | $-10,888 | $-8,114 | $-4,806 |
| EPS Basic Total Ops | -0.56 | -0.50 | 25.56 | -14.22 | -8.90 |
| EPS Basic Continuous Ops | -0.56 | -0.50 | 25.55 | -14.21 | -8.90 |
| EPS Diluted Total Ops | -0.56 | -0.50 | 25.56 | -14.22 | -8.90 |
| EPS Diluted Continuous Ops | -0.56 | -0.50 | 25.55 | -14.21 | -8.90 |
| EBITDA(a) | $-12,428 | $-11,135 | $-10,720 | $-7,789 | $-4,148 |